Shares of Check-Cap Ltd. (NASDAQ:CHEK – Get Free Report) crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.97 and traded as high as $1.79. Check-Cap shares last traded at $1.19, with a volume of 1,220,987 shares.
Analysts Set New Price Targets
Separately, StockNews.com assumed coverage on Check-Cap in a research report on Friday. They set a “sell” rating for the company.
Read Our Latest Report on Check-Cap
Check-Cap Stock Down 23.2 %
Check-Cap Company Profile
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.
Further Reading
- Five stocks we like better than Check-Cap
- Investing in the High PE Growth Stocks
- Top 3 Investment Themes to Watch for in 2025
- What Are the U.K. Market Holidays? How to Invest and Trade
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- Best Stocks Under $10.00
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.